Skip to main content
SteadySharesSteadySharesSteadyStShares
The market
MarketsDiscover
Follow the money
Super InvestorsPolitician TradesCrypto Desk
Yours
My WealthNews
Settings Sign in to save your work
Open
SteadySharesMarketsDiscoverSuper InvestorsMy WealthPoliticiansCryptoNews
DiscoverYDES
HealthcareNGMUSD

YD Bio Ltd

$00123456789.0012345678900123456789-1.3%
52w low (est.) $1.87$2.68 52w high (est.)
Market data · updated 4m ago
Market data
Market cap
USD160.79M
52w range
USD1.70 - USD25.00
Sector
Healthcare
Data quality
83/100
Valuation
DCF fair value
USD4.57
Margin of safety
+106.8%
Quality & efficiency
Moat score
26/100
Return on equity
-42.7%
Profit margin
-276.6%
Growth & analysts
Revenue growth
+95.6%
Run the 10-point checklist before you buy How these numbers are made

About YD Bio Ltd

YD Bio Limited a biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs. The company is based in Taipei, Taiwan.

Valuation

ValueGrowthProfitHealthIncome62QUALITY
Overall Rating
50
Hold
Hold

Derived from filed metrics · High confidence (83% of the inputs available)

Moat Score26
DCF Intrinsic Value
USD4.57+106.8% upside

Moat, DCF and rating computed by our valuation engine (ported from the original Python model).

Fundamentals

Market Cap
USD160.79M
P/E Ratio
N/A
Dividend Yield
0.00%
Revenue Growth
+95.6%
Profit Margin
-276.6%
ROE
-42.7%
Debt / Equity
0.00
Beta
-0.13
High GrowthBeaten Down
vs Healthcare sector:Moat 26 vs 7Yield 0.00% vs 0.3%

Statistics

Similar Stocks · Healthcare

LLY73
$920.00+0.7%
AZN.L72
£105.20+0.6%
UNH71
$492.10+1.6%
JNJ70
$146.20-0.2%

Latest News · YDES